Important Safety Information
Do not take BETASERON® (interferon beta-1b) if you are allergic to interferon beta-1b, to another interferon beta, to human albumin, or mannitol. See additional Important Safety Information below.

Alt tag

BETASERON®

and Its Heritage

Models used for illustrative purposes only.

Indications

BETASERON® (interferon beta-1b) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

BETASERON® (interferon beta-1b) can help

Effective Therapy. Proven Results.

In patients with clinically isolated syndrome (CIS), BETASERON® was PROVEN to

  • Significantly delay time to a second flare-up Significantly delay time to a second flare-up Return to content
  • Reduce the number of newly active brain lesions Reduce the number of newly active brain lesions Return to content
  • In patients with relapsing-remitting multiple sclerosis (RRMS), BETASERON was PROVEN to

  • Cut the frequency of flare-ups Cut the frequency of flare-ups Return to content
  • Learn more about efficacy

    Understand Safety

    It's important to know the possible risks and benefits of BETASERON. Make sure you talk to your doctor to understand which possible side effects are more serious than others, as well as those that are more common.

    Learn more about safety

    IMPORTANT SAFETY INFORMATION (CONT'D)

    BETASERON can cause serious side effects, including:

    Liver Problems Including Liver Failure. Symptoms of liver problems may include yellowing of your eyes, itchy skin, feeling very tired, flu-like symptoms, nausea or vomiting, bruising easily or bleeding problems. Your healthcare provider will do blood tests to check for these problems while you take BETASERON.

    Please see additional Important Safety Information below.

    Our Heritage

    BETASERON®’s heritage

    1995

    BETAPLUS® Launch

    Launch of the first MS patient support program now known as BETAPLUS

    BETASERON®'s (interferon beta-1b) heritage

    2002

    FDA Approval: Fridge-FREE Formula

    Refrigeration-FREE formulation for BETASERON

    BETASERON®’s heritage

    2008

    FDA Approval: A Thin Needle

    BETASERON offers one of the thinnest needles in relapsing forms of MS (30-gauge)

    BETASERON®’s heritage

    2015

    FDA Approval: BETACONNECT™

    The first electronic
    autoinjector for
    relapsing forms of MS

    BETASERON®’s heritage

    2019

    FDA Approval: Expanded Indication

    BETASERON approved
    for relapsing forms of MS
    to include clinically
    isolated syndrome,
    relapsing-remitting disease,
    and active secondary
    progressive disease, in adults

    BETASERON®'s (interferon beta-1b) heritage

    1993

    FDA Approval

    BETASERON®, the first disease-modifying therapy approved to treat RRMS

    BETASERON®’s heritage

    2001

    24/7/365 Support

    BETAPLUS support offers nurse support 24/7/365

    BETASERON®’s heritage

    2006

    FDA Approval: Expanded Indication

    BETASERON approved for patients with clinically isolated syndrome (CIS)

    BETASERON®’s heritage

    2011

    myBETAapp™ Launch

    Launch of myBETAapp, an injection-tracker app

    BETASERON®’s heritage

    2017

    FDA Approval: myBETAapp and BETACONNECT™ Navigator

    An app that receives injection data wirelessly from a Bluetooth®-enabled autoinjector, and sends the data to the BETA Nurse and healthcare team via the BETACONNECT Navigator

    Our Heritage

    BETASERON®'s (interferon beta-1b) heritage

    1993

    FDA Approval

    BETASERON®, the first disease-modifying therapy approved to treat RRMS

    BETASERON®’s heritage

    1995

    BETAPLUS® Launch

    Launch of the first MS patient support program now known as BETAPLUS

    BETASERON®’s heritage

    2001

    24/7/365 Support

    BETAPLUS support offers nurse support 24/7/365

    BETASERON®’s heritage

    2002

    FDA Approval: Fridge-FREE Formula

    Refrigeration-FREE formulation for BETASERON

    BETASERON®’s heritage

    2006

    FDA Approval: Expanded Indication

    BETASERON approved for patients with clinically isolated syndrome (CIS)

    BETASERON®’s heritage

    2008

    FDA Approval: A Thin Needle

    BETASERON offers one of the thinnest needles in relapsing forms of MS (30-gauge)

    BETASERON®’s heritage

    2011

    myBETAapp™ Launch

    Launch of myBETAapp, an injection-tracker app

    BETASERON®’s heritage

    2015

    FDA Approval: BETACONNECT™

    The first electronic
    autoinjector for
    relapsing forms of MS

    BETASERON®’s heritage

    2017

    FDA Approval: myBETAapp and BETACONNECT™ Navigator

    An app that receives injection data wirelessly from a Bluetooth®-enabled autoinjector, and sends the data to the BETA Nurse and healthcare team via the BETACONNECT Navigator

    BETASERON®’s heritage

    2019

    FDA Approval: Expanded Indication

    BETASERON approved
    for relapsing forms of MS
    to include clinically
    isolated syndrome,
    relapsing-remitting disease,
    and active secondary
    progressive disease, in adults

    For the first time, you have the ability to record, track, and share your injection data to update your BETA Nurse and healthcare team.* Your BETA Nurse can follow your progress and support you if needed. Whether it’s helping to identify your injection patterns or ensuring you are rotating injection sites properly and not missing injections, they are with you every step of the way.

  • Automatically capture your injections with BETACONNECT (date, time, speed, and depth)* Automatically capture your injections with BETACONNECT (date, time, speed, and depth)* Return to content
  • Pair and sync BETACONNECT with myBETAapp and track your progress Pair and sync BETACONNECT with myBETAapp and track your progress Return to content
  • Give your doctor the most accurate information you can, automatically* Give your doctor the most accurate information you can, automatically* Return to content
  • The BETACONNECT system

    USB plug, BETASERON® (interferon beta-1b)

    1. Treat

    with BETASERON
    using BETACONNECT

    Alt tag

    2. Track

    with myBETAapp

    Alt tag

    3. Share*

    via BETACONNECT™ Navigator
    (for healthcare professionals only)

    *When using the BETACONNECT autoinjector, injection data are automatically transferred to myBETAapp whenever the autoinjector is powered on and within range of a patient’s mobile device. myBETAapp must be open and running in order for data transfer to occur. Healthcare professionals must have BETACONNECT Navigator access, and a patient must enable sharing in myBETAapp for HCPs to obtain this information. Please note: If a patient is not using BETACONNECT to administer injections, he/she can also record injections manually. Patients are able to modify the details or delete injection data manually recorded in myBETAapp.

    Be prepared for your next doctor visit

    BETAPLUS is there 24/7, BETASERON® (interferon beta-1b)

    Questions? Call 1-844-788-1470

    An MS-trained BETA Nurse is available 24/7 to answer your questions about BETASERON.

    Where to Next?

  • Resources Resources Return to content
  • BETACONNECT system BETACONNECT system Return to content
  • BETAPLUS Patient Support Program BETAPLUS Patient Support Program Return to content
  • HCP BUTTON TEST Key BUTTON TEST